The Journal of Heart and Lung Transplantation
International Society for Heart and Lung Transplantation.
Abstract| Volume 27, ISSUE 2, SUPPLEMENT , S177, February 2008

323: Immunosuppressive Therapy Mitigates Murine T-Cell Mediated Rejection of Human Embryonic Stem Cells Following Transplantation

      Although human embryonic stem cells (hESC) are promising in cardiovascular regeneration therapy, potential host immune response towards transplanted hESC is not well characterized. We hypothesize that hESC transplantation elicits an adaptive murine immune response that may be modulated by immunosuppressive drugs.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The Journal of Heart and Lung Transplantation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect